Toenail Fungus (Onychomycosis): The Complete Guide

Toenail fungus, or onychomycosis, is the most common nail disease I treat, and the single most useful fact about onychomycosis treatment is this: the combination of an oral antifungal plus a penetration-enhanced topical reaches mycological cure of about 85%, up to roughly 88% in a randomized trial, compared with under 10% for the drugstore bottles most people try first (Shemer 2005). It affects around 1 in 10 Americans and up to half of adults over 70 (AAD). It won't clear on its own. And because a toenail grows out slowly, treating it is a project measured in months, not weeks. This guide walks through how to recognize it, how to be sure it's actually fungus, and which regimens genuinely work. Individual results vary.

What is onychomycosis, and how common is toenail fungus?

Onychomycosis is a fungal infection of the nail unit, the plate, the bed underneath, and sometimes the matrix where the nail is made. Toenails take the brunt of it. In adults, it's the most common form of dermatophytosis, the most frequent fungal infection dermatologists diagnose in the nail (Barac 2024).

It's also a condition of aging. The American Academy of Dermatology puts prevalence at roughly 10% of the general population, about 20% of adults over 60, and about 50% of adults over 70, rising to up to 75% of adults over 75. Nails grow more slowly with age, circulation to the feet drops, and the immune system loses a step, so the fungus gets more time and less resistance. It accounts for about half of all nail abnormalities, which is exactly why the other half matters so much (more on that below).

What causes toenail fungus?

Most toenail fungus is one family of organisms. Dermatophytes, fungi that feed on keratin, cause about 85 to 90% of cases, and the single most common species is Trichophyton rubrum, followed by T. interdigitale (Barac 2024). A minority of infections come from non-dermatophyte molds or yeasts such as Candida, and those can respond differently to treatment, which is one reason identifying the organism can change the plan.

There's a newer wrinkle worth knowing. A terbinafine-resistant dermatophyte, Trichophyton indotineae, is emerging and spreading internationally (Barac 2024). It's still uncommon in nail disease, but it's a real reason not to treat every thick nail with a reflexive course of the same oral drug without confirming what you're dealing with.

The infection usually starts small. Fungi don't need a dramatic injury, just a microscopic opening, a hangnail, a tiny split between nail and bed, an aggressive pedicure. They settle into the warm, dark, slightly damp space under the nail plate, which shields them from your immune system and from most topical drugs. That protection is the whole reason onychomycosis is so stubborn.

How do you recognize toenail fungus?

The classic presentation is distal subungual onychomycosis, or DSO, which is about 90% of cases (AAD). The fungus enters at the free edge, the tip, and works backward toward the cuticle. Here's what that looks like as it progresses:

• Discoloration that starts at the tip: yellow, white, brown, or, in darker skin tones, a deeper brown rather than yellow.
• Thickening, because the fungus drives up keratin production. This is the symptom that finally gets most patients into my office, because a thick nail stops fitting comfortably in a shoe.
• Onycholysis, the nail lifting away from the bed, leaving a gap where debris collects.
• Subungual debris, that chalky, crumbly buildup under the nail, a mix of fungal organisms and broken-down nail.
• Brittleness and crumbling at the edges, and in advanced cases a misshapen nail that can loosen or fall off.

Pain is usually late. Early onychomycosis rarely hurts, which is part of why people ignore it for months. By the time it's uncomfortable in a shoe, the infection is well established and harder to clear.

Is it really fungus, or something else?

This is the question I wish more people asked before spending money on treatment. Onychomycosis accounts for about half of abnormal nails, which means the other half of thick, discolored, or crumbling nails are something else entirely, and those won't respond to an antifungal no matter how long you use it.

The most common impostor is nail psoriasis, which produces pitting, thickening, oil-drop discoloration, and separation that can look identical to fungus. Nail changes affect nearly 80% of people with plaque psoriasis (Manhart & Rich 2015, PMID 26472140). Repetitive trauma from running or tight shoes causes discoloration and thickening that mimics infection. Lichen planus, chronic eczema, and, rarely but importantly, a melanoma appearing as a dark streak under the nail, all live on the differential. A pigmented band that's new, changing, or widening is worth an in-person exam, not a bottle of antifungal.

Do you need testing or a doctor for toenail fungus?

For a clear-cut, classic case, an experienced clinician can often recognize it. But testing earns its keep here, because the treatments are months long and, in the case of oral drugs, carry real considerations. The standard confirmatory tests are a KOH prep, a fungal culture, or a PAS stain of a nail clipping. No test is perfect; a fungal study can come back falsely negative, so a single negative doesn't rule it out, but a positive confirms what you're aiming at and can identify the organism.

Most people skip this entirely. Only about 25% of onychomycosis cases are ever seen by a dermatologist; 61.4% are self-diagnosed, and 55.5% reach for OTC antifungals without a clinician (J Fungi). That self-treatment gap is a big part of why so many "stubborn" cases were either misdiagnosed or undertreated from the start. If you want help deciding whether your case needs a professional, do you need a doctor for toenail fungus is the place to start.

Access is the other half of the problem. About 55% of patients wait three or more months for a dermatology appointment, an average around 2.5 months; 38.7% report their condition worsening during the wait, and 65.5% turn to OTC or herbal remedies because of the delay (Cureus). That's exactly the window where a treatable early infection becomes an entrenched one. For patients who can't wait months for an in-person slot, whether toenail fungus can be treated online covers what a remote evaluation can and can't do.

What are the treatment options for toenail fungus (onychomycosis)?

Three broad approaches exist: topical, oral, and the two combined. They are not equal.

Why topical alone is limited

Topical antifungals have to cross the nail plate to reach the infection underneath, and very little drug actually gets through. That penetration barrier is the core reason topical-only regimens and OTC bottles underperform (Gupta 2013). Prescription lacquers and solutions outperform drugstore products, but as a single agent for a thick toenail with an involved matrix, topical therapy has a real ceiling. It's most useful for superficial disease, early distal involvement of a thin nail, patients who can't take an oral drug, and as a partner to an oral drug rather than a replacement for it.

What oral antifungals do

Oral terbinafine is the workhorse. The standard toenail course is 250 mg daily for 12 weeks, which delivers drug to the nail through the bloodstream and the nail bed, the side topical drugs can't reach. But even done correctly, one drug alone leaves a gap. In a controlled comparison, terbinafine pulse dosing produced mycological clearance of 48.9% and complete clearance of 32.2%, while a sequential itraconazole-then-terbinafine regimen reached 72.0% mycological and 52.0% complete clearance at 72 weeks (Gupta 2001). Those numbers are honest: oral monotherapy helps a lot of people, and still misses a meaningful share.

Terbinafine also holds up better over time than its main oral alternative. In the five-year LION follow-up, 46% of terbinafine-treated patients remained disease-free versus 13% of those treated with itraconazole (Olafsson 2003). That durability is why terbinafine is the preferred oral agent for most dermatophyte nail infections.

Why combination therapy wins

Here's the part that changes outcomes. Attacking the fungus from both sides, an oral drug through the bloodstream and a topical through the nail plate, beats either one alone. In a randomized trial, oral terbinafine plus a topical ciclopirox nail lacquer reached 88.2% mycological cure, compared with 64.7% for oral terbinafine by itself (Shemer 2005). The two routes cover each other's weak spots: the oral drug saturates the nail bed and matrix that a topical can't reach, while the topical keeps a hostile drug concentration right at the plate where reinfection tends to start. A typical regimen pairs the standard 12-week oral course with a daily topical, then follows new growth out over the year that follows. That's the roughly 85% figure you see quoted for modern dual therapy, and it's the strategy I lean on in practice. Individual results still vary with the organism, the severity, and how consistently the regimen is followed. For a deeper comparison of the two drug routes, see oral vs. topical toenail fungus treatment.

A dermatologist-designed prescription program built around this dual approach, a prescription nail treatment that works from both sides of the nail, reflects the same logic. KindleeRx patients are evaluated by licensed clinicians working under a board-certified dermatologist's protocols, and a clinician decides whether treatment is appropriate for you.

How long does toenail fungus take to clear?

Longer than almost anyone expects, and it's worth setting that expectation up front. A great toenail grows at about 1 to 1.5 mm per month and takes roughly 12 to 18 months to fully grow out. Because of that pace, the nail keeps looking abnormal for months after the fungus is dead; you're waiting for healthy new nail to replace the damaged part, not for the old nail to repair itself.

That's why we don't judge success by how the nail looks at week 12. We judge it by new clear growth advancing from the base, and we assess the result at about the 12-month mark. Here's the sequence I have patients watch for: a thin band of normal-looking nail emerging at the cuticle first, then that healthy band slowly pushing the discolored portion toward the tip over the following months, where it's eventually trimmed away. The stubborn great toenail is the slowest of all, which is why 18 months isn't unusual for that one. Patients who quit at three months because "nothing changed" are often quitting on a treatment that's actually working; the drug's job finished long before the nail's appearance caught up.

Will toenail fungus come back, and how do you prevent it?

Recurrence is genuinely common, and pretending otherwise does patients no favors. Relapse and reinfection happen even after a good response, which is part of why the durable-agent choice matters; recall that five years out, 46% of terbinafine-treated patients stayed disease-free versus 13% on itraconazole (Olafsson 2003). A good clearance today is not a promise against a new infection tomorrow.

Prevention is where you have leverage. Athlete's foot is caused by the same organisms and is the number-one pathway back into the nail, so treat it whenever it shows up. Keep feet clean and dry, rotate shoes so each pair airs out a full day, use moisture-wicking socks, wear sandals in locker rooms and pool decks, disinfect nail clippers, and don't share grooming tools. After finishing treatment, disinfect or replace the shoes you wore while infected. The full maintenance routine lives in how to stop toenail fungus from coming back.

What about toenail fungus with diabetes or poor circulation?

This is the group where nail fungus stops being cosmetic. In people with diabetes, onychomycosis prevalence runs about 36.9% versus 17.5% in those without, an odds ratio near 2.75 (Navarro-Perez 2024). In a large diabetes cohort, onychomycosis affected 14.5% of people with type 1 and 28.7% with type 2, and nail thickening was independently associated with foot ulceration (Aronson 2020).

The reason to take it seriously isn't the nail's appearance, it's what a thick, crumbling, lifting nail can lead to. A thickened, sharp-edged nail presses and rubs against adjacent toes and the inside of the shoe, and in a foot with reduced sensation the small breaks in skin that follow go unnoticed. Those breaks become an entry point for bacteria, and that's how a cosmetic problem turns into cellulitis or a diabetic foot ulcer. Anyone with diabetes, peripheral vascular disease, or neuropathy should have fungal nails evaluated as part of comprehensive foot care with their own physician or podiatrist, not managed as an isolated nail issue. Our guide to toenail fungus with diabetes or poor circulation covers the higher-stakes version of this problem.

The bottom line

Toenail fungus is common, it's real, and it's treatable, but it rewards a clear-eyed plan over wishful thinking. Confirm it's actually fungus, because about half of abnormal nails aren't. Understand that OTC bottles clear fewer than 10% of infections because the drug can't get through the nail (Gupta 2013). Know that the combination of an oral antifungal and a penetration-enhanced topical reaches mycological cure around 85% (Shemer 2005), and that you'll be judging progress over 12 to 18 months of new growth. Individual results vary, and the right plan depends on your nails, your health, and an accurate diagnosis. If you're ready to treat it properly, a clinician-reviewed prescription regimen is the most effective path most patients have.

Sources

• Shemer A, et al. J Dermatolog Treat. 2005;16(5-6):327-30. doi:10.1080/09546630500420183
• Gupta AK, Lynde CW, Konnikov N. J Am Acad Dermatol. 2001;44(3):485-91. doi:10.1067/mjd.2001.110644
• Olafsson JH, Sigurgeirsson B, Baran R (LION study, 5-year follow-up). Br J Dermatol. 2003;149 Suppl 65:15-8. doi:10.1046/j.1365-2133.149.s65.2.x
• Barac A, et al. Mycopathologia. 2024;189(6):101. doi:10.1007/s11046-024-00909-3
• Gupta AK, Simpson FC. Expert Opin Investig Drugs. 2013;23(1):97-106. doi:10.1517/13543784.2013.840289
• Navarro-Perez D, et al. J Fungi (Basel). 2024;10(11):790. doi:10.3390/jof10110790
• Aronson R, et al. Can J Diabetes. 2020;45(7):588-593. doi:10.1016/j.jcjd.2020.11.011
• Manhart R, Rich P. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S7-13. PMID 26472140
• Onychomycosis diagnosis and self-treatment patterns (25% ever seen by a dermatologist; 61.4% self-diagnosed; 55.5% self-treat with OTC). J Fungi (Basel). doi:10.3390/jof9010019
• Dermatology appointment wait times and recourse to OTC/herbal remedies (55% wait 3+ months; 38.7% worsen while waiting; 65.5% use OTC/herbal). Cureus. doi:10.7759/cureus.101556